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Tuesday, February 8 
Educational Session: Fundamentals in Proteomics 
Chairs: Dr. Alberto Paradela, Dra. Lucía Monteoliva, Dr. Miguel Marcilla 
 
 




Dr. Juan Pablo Albar (CNB-CSIC) 
10:00-10:45 
Proteomics: basic concepts. 
Dr. Joaquin Abian (IIBB-CSIC) 
10:45-11:30 
Differential Proteomics: advantages and disadvantages of gel-based 
strategies. 
Dr. Montserrat Martínez-Gomariz (PCM-UCM) 
11:30-12:00 Coffee break 
12:00-12:45 
Differential Proteomics: advantages and disadvantages of LC-MS-
based strategies. 
Dr. Miguel Marcilla (CNB-CSIC) 
12:45-13:30 
Protein Databases: a useful guideline. 
Dr. José Ramón Valverde (CNB-CSIC) 
13:30-14:15 
Statistical analysis of proteomics data. 
Antonio Ramos (CNB-CSIC) 
14:15-15:30 Lunch time 
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Session II: Sample preparation 
 
15:30-16:00 
Subcellular fractionation and membrane proteomics. 
Dr. Lucia Monteoliva (UCM) 
16:00-16:30 
Phosphoproteomics. 
Dr. Mª Luisa Hernaez (Parque Científico de Madrid – UCM) 
16:30-17:00 Coffee break 
17:00-17:30 
Plasma Proteomics. 
Sergio Ciordia (CNB) 
17:30-18:00 
Peptidomics: Proteomic Analysis of MHC peptides. 





 CNB-CSIC (Centro Nacional de Biotecnología-Consejo Superior de 
Investigaciones Científicas) 
 IIBB-CSIC (Instituto de Investigaciones Biomédicas de Barcelona-
Consejo Superior de Investigaciones Científicas) 
 PCM (Parque Científico de Madrid) 
 UCM (Universidad Complutense de Madrid) 
 UAB (Universidad Autónoma de Barcelona) 
 
 
Sponsored by ProteoRed 
Opening Lectures Scientific Program 
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Tuesday, February 8 
Opening Lectures 











A life with gels: from ultrathin gels to IPG-Dalt 
Dr. Angelika Görg (Technische Universität München, Fachgebiet 
Proteomik, Freising-Weihenstephan, Germany) 
19:30-20:00 
Deep Proteomics provides New Insights in Fundamental Cellular 
Mechanisms 
Dr. Joel Vandekerckhove (Department of Medical Protein Research, 
Ghent University, Ghent, Belgium) 
21:00 Welcome reception 
 
Sponsored by ProteoRed and Cátedra de Genómica y Proteómica UCM 
Scientific Program S1. Quantitative Proteomics 
27 
 
Wednesday, February 9 
Session 1: Quantitative Proteomics 




Mapping and measuring complete proteomes 
Dr. Ruedi Aebersold (Institute of Molecular Systems Biology-ETH, 
Zurich, Switzerland) 
09:00-09:30 
Advances in quantitative proteomics: applications to cardiovascular 
research 
Dr. Jesús Vázquez (Centro de Biología Molecular Severo Ochoa-CSIC, 
Madrid,  Spain) 
09:30-10:00 
Physiological proteomics of Gram-positive bacteria 
Dr. Jörg Bernhardt (Institut für  Mikrobiologie, E.-M.-Arndt-Universität 




Qualitative and quantitative characterization of exosomes secreted by 
rat hepatocytes 
Dr. Eva Rodríguez-Suárez  (CICbioGUNE, Derio, Spain) 
10:15-10:30 
SWATH-MS: a new data independent acquisition lc-ms methodology 
for quantitative complete proteome analysis 
Dr. Pedro Navarro
 
(Institute of Molecular Systems Biology, ETH Zürich, 
Switzerland) 
10:30-10:45 
High resolution targeted proteomics: biomarker discovery in a mouse 
transgenic model of myopathy. 
Dr. Claire Dauly (Thermo Scientific) 
 
Sponsored by Thermo Scientific 
 
 
10:45-11:15 Coffee Break 
 
S2: Microbial Proteomics Scientific Program 
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Wednesday, February 9 
Session 2: Microbial Proteomics 




Analysis of genome expression of Rhizobium etli in free living and 
plant-associated symbiotic state 
Dr. Sergio Encarnación (Centro de Ciencias Genómicas, Universidad 
Nacional Autónoma de México, Cuernavaca, Mexico) 
11:45-12:15 
The Crc protein, a translational repressor that coordinates carbon 
metabolism  in Pseudomonas 
Dr. Fernando Rojo (Centro Nacional de Biotecnología-CSIC, Madrid, 
Spain) 
12:15-12:45 
Quantitative phosphoproteomics by SILAC-2-DE/MALDI-MS in 
Helicobacter pylori infected AGS cells 
Dr. Peter Jungblut (Core Facility Protein Analysis, Max-Planck Institute 




Proteomics applications to tick research 
Dr. Margarita Villar
 
 (Instituto de Investigación en Recursos Cinegéticos 
IREC (CSIC-UCLM-JCCM),Ciudad Real, Spain) 
13:00-13:15 
Proteomic and phosphoproteomic study of the macrophage response 
to candida albicans using silac and simac 
Dr. Jose A. Reales-Calderón
 
 (Facultad de Farmacia, Universidad 
Complutense de Madrid, Madrid, Spain) 
13:15-13:30 
ProteOn XPR36: Powerful and flexible protein-to-protein interaction 
analysis 
Dr. Marc Martin (Biorad Laboratories) 
 
Sponsored by BIO RAD 
 
13:30-14:30 Lunch 
14:30-15:15 Poster Session 
Scientific Program Quality Control and Standardization in Proteomics Session 
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Wednesday, February 9 
Quality Control and Standardization in Proteomics 
Session 




QC in proteomics: lessons from Proteored multicentric experiments 
Dr. Francesc Canals (Laboratori de Proteomica, Institut de  Recerca- 
Hospital Universitari Vall d'Hebron, Barcelona, Spain) 
15:35-15:55 
Quality Control of Proteomics Data: performing local as well as 
global  analyses 
Dr. Lennart Martens (Department of Medical Protein Research, VIB, 
Gent, Belgium) 
15:55-16:15 
Quality control and standardization efforts at the PRoteomics 
IDEntifications  (PRIDE) database 
Dr. Juan Antonio Vizcaino (European Bioinformatics Institute, Hinxton 
Cambridge, England) 
 
Sponsored by Promega 
HUPO and EuPA Initiatives Session Scientific Program 
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Wednesday, February 9 
HUPO and EuPA Initiatives Session 
 




The gene-centric Human Proteome Project: organisation, scope and 
limitations 
Dr. Thierry Rabilloud (Biochemistry and Biophysics of Integrated 
Systems, CEA Grenoble, iRTSV/BSBBSI, Grenoble, Francia) 
16:45-17:15 
Differential Protein Expression Analysis in Patients within Lung 
Cancer Studies 
Dr. Gyorgy Marko-Varga  (Clinical Protein Science and Imagining, Dpt. 
Measurement Technology and industrial Electrical 
Engineering,  University of Lund, Lund, Sweden) 
Sponsored by Agilent Technologies 
Scientific Program S3: Post-Translational Proteomics 
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Thursday, February 10 
Session 3: Post-Translational Proteomics 
 
Chairs: Dr. Montserrat Carrascal and Dr. Juan José Calvete 
Plenary Lectures 
08:30-09:00 
Modification specific proteomics; Identification and quantitation of 
phosphorylated proteins and sialylated glycoproteins derived from 
primary biological material. 
Dr. Martin Larsen (Department of Biochemistry and Molecular 
Biology.University of Southern Denmark, Odense, Denmark) 
09:00-09:30 
Quantitative characterization of p-sites from the human T-
lymphocyte phosphoproteome using isotopic labeling and mass 
spectrometry 
Dr. Joaquin Abian (Laboratori de Proteómica-CSIC-Universitat 
Autónoma de Barcelona, Barcelona, Spain) 
09:30-10:00 
Unraveling cancer signaling pathways using global phosphoproteomic 
approaches 
Dr. Akhilesh Pandey (McKusick-Nathans Institute of Genetic Medicine, 
Departments of Biological Chemistry, Oncology, Pathology, Johns-




Differential redox proteomics allows identification of proteins 
reversibly oxidized in cysteines in endothelial cells in respone to acute 
Dr. Antonio Martínez-Ruiz (Hospital Universitario de La Princesa, 
Instituto de Investigación Sanitaria Princesa (IP), Madrid, Spain) 
10:15-10:30 
New clues to metabolic regulation through changes in the thiol redox 
proteome 
Dr. Jose A. Bárcena
 
(University of Córdoba, Córdoba, Spain) 
10:30-10:45 
The implementation and characterization of electron transfer 
dissociation (ETD) on an ion mobility enabled Q-TOF mass 
spectrometer. 




10:45-11:15 Coffee Break 
S4: Structural Proteomics: Interactions, Networks and Complexes Scientific Program 
32 
 
Thursday, February 10 
Session 4: Structural Proteomics: Interactions Networks 
and Complexes 
 




Combining 3D structures with protein quantification to understand 
cell type specific epidermal growth factor receptor signal processing 
Dr. Christina Kiel (EMBL-CRG Systems Biology Unit, Design of 
Biological   Systems, Centre de Regulació Genòmica, Barcelona, Spain). 
11:45-12:15 
Determination and analysis of protein interaction networks 





Phosphorylation-based signaling networks mediate the effect of ligand 
affinity on the activation of naive primary t-cells 
Dr. Mónica Carrera
 
(Institute of Molecular Systems Biology, ETH, 
Zürich, Switzerland) 
12:30-12:45 
Intensity-fading and other ms approaches to analyze proteases and 
protease inhibitors and their interactions in biological samples 
Dr. Francesc X. Aviles
 
 (Institut de Biotecnologia i de Biomedicina (IBB) 
& Dept. Bioquímica, Universitat Autonoma de Barcelona, Barcelona, 
Spain) 
12:45-13:00 
Helping resolve the interactome by means of label free interaction 
analysis. 
Dr. Silvia Pileri. (GE Healthcare). 
 
Sponsored by GE Healthcare 
 
13:15-14:15 Lunch 
14:15-15:00 Poster Session 
Scientific Program S5: Computational Proteomics 
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Thursday, February 10 
Session 5: Computational Proteomics 
 




Computational methods for exploring protein isoforms based on MS 
data 
Dr. Rhune Matthiesen (Instituto de Patologia e Imunologia Molecular da 
Universidade do Porto (IPATIMUP), Porto, Portugal) 
15:30-16:00 
Computer-aided identification of potential drug targets and 
vaccine   candidates in bacterial proteomes 
Dr. Xabier Daura Ribera (Institut de Biotecnología i Biomedicina (IBB), 
Universitat Autònoma de Barcelona, Barcelona, Spain) 
16:00-16:30 
neXtProt: the new human protein knowledge resource 
Dr. Amos Bairoch (Swiss Institute of Bioinformatics. Dpt. of Structural 
Biology and Bioinformatics, Genève, Switzerland) 
16:30-17:00 
Dedicated resources for PTM identification 





MIAPE web toolkit: a user-friendly work frame to connect and share 
proteomics standards in the lab 
Dr. J.Alberto Medina-Aunon (Centro Nacional de Biotecnología-
CSIC/ProteoRed, Madrid, Spain) 
17:15-17:30 
A general statistical framework for the integration and ontological 
analysis of quantitative proteomics experiments by stable isotope 
Marco Trevisan-Herraz (Centro de Biología Molecular Severo Ochoa-
CSIC-UAM, Madrid, Spain) 
17:45-18:15 Coffee Break 
18:15-19:15 
SEProt Awards  
(Sponsored by Bruker Daltonics and Celta Ingenieros) 
19:15-20:15 SEProt General Meeting 
 
21:00 Congress Dinner 
S6: Biomarker Discovery and Validation Scientific Program 
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Friday, February 11 
Session 6: Biomarker Discovery and Validation 
Chairs: Dr. Ignacio Casal and Dr. Ángel García 
Plenary Lectures 
09:30-10:00 
Sleeping sickness biomarkers: the quest for a neglected disease holy 
grail 
Dr. Jean Charles Sanchez (Biomedical Proteomics Group, Department of 
Structural Biology and Bioinformatics, Faculty of Medicine, University  of 
Geneva, Switzerland) 
10:00-10:30 
Biomarker Discovery for diagnostic, prognostic and therapeutic 
response in Rheumatic Diseases 
Dr. Francisco Blanco (Plataforma de Proteómica INIBIC-CHUAC,  A 
Coruña, Spain) 
10:30-11:00 
Label-free quantitative proteomics targeted to sub-cellular 
compartments for candidate biomarker discovery in colorectal cancer 
Dr. Connie Jimenez (Department of Medical Oncology,OncoProteomics 





Proteins involved in platelet activation by GPVI and alphaiibbeta3 
receptors are differentially regulated in acute coronary syndrome: a 
platelet proteomics study 
Dr. Andrés F. Parguiña
 
(Universidade de Santiago de Compostela, 
Santiago de Compostela, Spain) 
11:15-11:30 
Early diagnostic of B cell chronic leukemia by novel biomarkers. 
Dr. Manuel Fuentes
 
 (Centro de Investigación del Cáncer, Universidad de 
Salamanca-CSIC, Salamanca, Spain) 
11:30-11:45 
Simultaneous compound Quantification and Identification using High 
Resolution MS: The AB SCIEX TripleTOF™ 5600 System.  
Dr. Antonio Serna (ABSciex) 
 
Sponsored by AB Sciex 
 
11:45-12:15 Coffee Break 
Scientific Program Closing Lecture 
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Friday, February 11 
Closing Lecture 




In taberna quando sumus: a drunkard's cakewalk through 
proteomics 
Dr. Pier Giorgio Righetti (Politecnico di Milano, Department of 
Chemistry, Milan,  Italy) 
13:30 Farewell 
Sponsored by ProteoRed and Cátedra de Genómica y Proteómica UCM 
